BSE · 543943
Asarfi Hospital Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹45 Cr with net profit ₹4 Cr — a 9.08% net margin, versus 11.9% the period before.
Shareholding
As of 2026-06-30
- Promoter61.17%
- Public35.86%
- DII2.97%
1,399 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.19× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #34 of 79 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,28,472 Cr | 242.67 | 13.55 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,08,166 Cr | 315.74 | 10.06 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹71,876 Cr | 270.47 | 7.26 | 10.53% | 11.41% |
| Narayana Hrudayalaya Ltd. | ₹42,315 Cr | 187.89 | 9.33 | 17.76% | 10.2% |
| Aster DM Healthcare Ltd. | ₹42,227 Cr | 299.63 | 9.23 | 8.48% | 8.36% |
| Global Health Limited | ₹38,526 Cr | 267.33 | 9.72 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹31,931 Cr | 752.83 | 14.2 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,558 Cr | 239.5 | 12.58 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹17,015 Cr | 256.67 | 5.48 | 10.37% | 17.18% |
| Dr. Agarwal's Health Care Limited | ₹15,494 Cr | 391.04 | 7.65 | 6.58% | 6.4% |
| Asarfi Hospital Limited(this company) | ₹409 Cr | 24.56 | 4.19 | 17.06% | 9.69% |
AI analysis
AI-generated · google/gemini-2.5-flashAsarfi Hospital Limited is listed with a market capitalization of Rs 421 Cr. The company reported revenue of Rs 128.09 Cr and a profit margin of 9.69%. Its earnings per share (EPS) stands at Rs 8.47, with a price-to-earnings (PE) ratio of 25.29.
Positives
- +The promoter holding is substantial at 61.1699% as of June 30, 2026.
- +The debt-to-equity ratio is 0.53, indicating a manageable level of debt.
- +The company's return on equity (ROE) is 17.06%.
- +Return on capital employed (ROCE) is 16.2747%.
Negatives
- −No dividend yield has been reported (0%).
- −Revenue growth for the company is not disclosed.
- −No quarterly EPS figures are available in the provided data since March 2025.
Financial Performance
In the financial year ending March 2025, Asarfi Hospital Limited reported a revenue of Rs 128.0856 Cr and a net profit of Rs 10.5761 Cr. The company's earnings per share (EPS) for this period was Rs 5.37. For the quarter ending March 2026, revenue was Rs 45.24 Cr and net profit was Rs 3.92 Cr.
Profitability & Returns
Asarfi Hospital Limited has a profit margin of 9.69%. The company's return on equity (ROE) is 17.06%, while its return on capital employed (ROCE) is 16.2747%. The EPS for the latest annual period was Rs 8.47.
Balance Sheet
The company maintains a debt-to-equity ratio of 0.53, indicating its reliance on debt financing. The book value per share is Rs 49.62. No additional balance sheet figures are available in the provided data.
Ownership & Pledges
There are no reported promoter share pledges.
Shareholding History
Promoter holding has remained at 61.1699% since July 31, 2023. Institutional shareholding increased from 0% in March 2023 to 2.9679% in June 2026. Public shareholding has fluctuated, from 16.9736% in March 2023 to 35.8622% in June 2026.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.